雅润YaRun品牌怎么样 申请店铺

我要投票 雅润YaRun在成人用品行业中的票数:614 更新时间:2025-08-22
雅润YaRun是哪个国家的品牌?「雅润YaRun」是 重庆市海洁消毒卫生用品有限责任公司 旗下著名品牌。该品牌发源于重庆市,在2000年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力雅润YaRun品牌出海!将品牌入驻外推网,定制雅润YaRun品牌推广信息,可以显著提高雅润YaRun产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

雅润YaRun怎么样

重庆市海洁消毒卫生用品有限责任公司,雅润YaRun,专注于研发推广个人洁卫护理用品的企业,消毒卫生用品专业提供商

重庆市海洁消毒卫生用品有限责任公司是消毒卫生用品的专业生产厂家,创立于2000年。公司专注于开发和推广新型、广普、无毒副作用、无刺激、无污染、高效的系列个人卫生护理用品,走专业化发展道路。公司秉承“科技、人与自然和谐发展”的思想,致力做中国一流的个人洁卫护理专家!

公司目前自行研制开发成功的静香雅润漱口水及口腔护理液、雅润皮肤粘膜消毒液、雅润女性护理液、雅润洁阴湿巾、雅润人体润滑剂,已投入全国市场,产品畅销各地,深受消费者喜爱。

雅润人体润滑剂是海洁公司在详细研究当今市场中外产品的基础上,凝聚众多专家学者多年心血,结合当今最新科技成果,推出的新一代经典之作,其产品与同类产品相比有许多特别及过人之处。在日常大众生活中,产品润滑和消毒杀菌效果显著,对生殖系统炎症及性传播疾病等有明显的预防和辅助治疗作用,功效明显、经济实用、感觉舒适,消费者再次使用率高。

公司下属的海洁个人卫生用品护理研究院,拥有一大批专家学者组成的研发队伍,公司管理层及销售团队均由大专以上的高素质人员构成。公司具有现代化检测手段和严谨齐全的质量保证体系,保证了产品卓越的性能和过硬的质量,使公司能够在激烈的市场竞争中不断发展,不断进步和成长。


Chongqing Haijie disinfection and Health Products Co., Ltd., yarun, is a company specializing in the research and development and promotion of personal cleaning and health care products. Chongqing Haijie disinfection and Health Products Co., Ltd., a professional manufacturer of disinfection and health products, was founded in 2000. The company focuses on the development and promotion of new, universal, non-toxic side effects, no stimulation, no pollution, efficient series of personal health care products, and takes a professional development path. Adhering to the idea of "harmonious development of science and technology, human beings and nature", the company is committed to being a first-class personal cleaning and health care expert in China! At present, the company has developed its own Jingxiang yarun mouthwash and oral care solution, yarun skin and mucous membrane disinfectant, yarun women's care solution, yarun clean Yin wipes and yarun human body lubricant, which have been put into the national market, and the products are sold all over the country and are loved by consumers. Yarun human body lubricant is a new generation of classic works launched by Haijie company on the basis of detailed research on domestic and foreign products in today's market, the efforts of many experts and scholars for many years, combined with the latest scientific and technological achievements. Compared with similar products, its products have many special and outstanding points. In the daily life of the public, the product has a significant effect of lubrication, disinfection and sterilization. It has a significant role in prevention and auxiliary treatment of reproductive system inflammation and sexually transmitted diseases. It has obvious effect, economic and practical, comfortable feeling, and high re-use rate of consumers. Haijie personal hygiene products Nursing Research Institute under the company has a large number of experts and scholars composed of R & D team. The company's management and sales team are composed of high-quality personnel above junior college. The company has modern testing means and rigorous and complete quality assurance system, which ensures the excellent performance and excellent quality of products, and enables the company to develop, progress and grow in the fierce market competition.

本文链接: https://brand.waitui.com/5f4c5e34d.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

德国第二季度GDP被下修,萎缩幅度超过最初估计

德国第二季度经济萎缩幅度超过最初估计,制造企业的表现远逊于预期。统计部门周五公布,当季国内生产总值(GDP)环比下降0.3%,初值为下降0.1%。投资也是一大拖累因素,下降了1.4%,而私人消费对GDP的支撑作用远低于最初估计。(新浪财经)

2小时前

恒大地产广东公司被广州市中级人民法院裁定破产清算

8月22日,广州市中级人民法院在全国企业破产重整案件信息网发布公告称,该院已于8月20日裁定受理恒大地产集团广东房地产开发有限公司(下称“恒大地产广东公司”)破产清算一案,并依法指定清算组担任恒大地产广东公司管理人,恒大地产广东公司的债权人应在2025年11月20日前,向恒大地产广东公司管理人申报债权。这意味着,恒大地产广东公司已依法进入破产程序。(澎湃)

2小时前

英伟达要求部分零部件供应商暂停生产H20芯片,外交部回应

外交部发言人毛宁主持例行记者会。彭博社记者提问,据报道称,英伟达已要求部分零部件供应商暂停生产H20芯片。外交部对有关英伟达停止H20芯片生产的最新报道有何评论?对此,毛宁表示:“这个问题建议你向中方的主管部门了解。作为原则,我们一贯认为各方各国都应当共同维护全球产供链的稳定畅通。”(澎湃)

2小时前

东百集团:上半年归母净利润7155.67万元,同比增长2.40%

36氪获悉,东百集团发布半年报。财报显示,公司上半年实现营业收入9.29亿元,同比增长0.11%;归属于上市公司股东的净利润7155.67万元,同比增长2.40%;基本每股收益0.0823元。

2小时前

新诺威:控股子公司SYS6036注射液获得药物临床试验批准通知书

36氪获悉,新诺威公告,公司控股子公司巨石生物近日收到国家药品监督管理局核准签发的关于SYS6036注射液的《药物临床试验批准通知书》,同意按生物类似药开展临床试验。SYS6036注射液是一款肿瘤免疫治疗的人源化单克隆抗体药物,预计将适用于治疗多种肿瘤。但需注意,药物在获得《药物临床试验批准通知书》后,尚需开展临床试验,并经国家监管部门批准后方可上市、销售。同时,药物研发存在高投入、高风险、周期长等特点,存在多种风险。短期对巨石生物及公司业绩不会产生重大影响。

2小时前

本页详细列出关于雅润YaRun的品牌信息,含品牌所属公司介绍,雅润YaRun所处行业的品牌地位及优势。
咨询